These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 25943554)

  • 21. Efficacy and safety of potent platelet P2Y12 receptor inhibitors in elderly versus nonelderly patients with acute coronary syndrome: A systematic review and meta-analysis.
    Tarantini G; Ueshima D; D'Amico G; Masiero G; Musumeci G; Stone GW; Brener SJ
    Am Heart J; 2018 Jan; 195():78-85. PubMed ID: 29224649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ticagrelor: oral reversible P2Y(12) receptor antagonist for the management of acute coronary syndromes.
    Cheng JW
    Clin Ther; 2012 Jun; 34(6):1209-20. PubMed ID: 22521881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Head to head comparison of Prasugrel versus Ticagrelor in patients with acute coronary syndrome: a systematic review and meta-analysis of randomized trials.
    Bundhun PK; Shi JX; Huang F
    BMC Pharmacol Toxicol; 2017 Dec; 18(1):80. PubMed ID: 29233189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety of Prasugrel Loading Doses in Patients Pre-Loaded With Clopidogrel in the Setting of Primary Percutaneous Coronary Intervention: Results of a Nonrandomized Observational Study.
    Räber L; Klingenberg R; Heg D; Kelbæk H; Roffi M; Tüller D; Baumbach A; Zanchin T; Carballo D; Ostojic M; Stefanini GG; Rodondi N; von Birgelen C; Moschovitis A; Engstrøm T; Gencer B; Auer R; Meier B; Mach F; Lüscher TF; Jüni P; Matter CM; Windecker S;
    JACC Cardiovasc Interv; 2015 Jul; 8(8):1064-1074. PubMed ID: 26205445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative Effectiveness and Safety Analysis of Dual Antiplatelet Therapies Within an Integrated Delivery System.
    Coons JC; Iasella CJ; Chanas T; Wang N; Williams K; Boyd A; Lyons J; Eckardt J; Rihtarchik L; Merkel A; Chambers A; Lemon LS; Smith R; Ensor CR
    Ann Pharmacother; 2017 Aug; 51(8):649-655. PubMed ID: 28438043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical outcomes associated with per-operative discontinuation of aspirin in patients with coronary artery disease: A systematic review and meta-analysis.
    Luni FK; Riaz H; Khan AR; Riaz T; Husnain M; Riaz IB; Khan MS; Taleb M; Kanjwal Y; Cooper CJ; Khuder SA
    Catheter Cardiovasc Interv; 2017 Jun; 89(7):1168-1175. PubMed ID: 27663179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of ex vivo autologous and in vivo platelet transfusion in the reversal of P2Y12 inhibition by clopidogrel, prasugrel, and ticagrelor: the APTITUDE study.
    O'Connor SA; Amour J; Mercadier A; Martin R; Kerneis M; Abtan J; Brugier D; Silvain J; Barthélémy O; Leprince P; Montalescot G; Collet JP;
    Circ Cardiovasc Interv; 2015 Nov; 8(11):e002786. PubMed ID: 26553698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A model-based analysis of the clinical and economic impact of personalising P2Y12-receptor inhibition with platelet function testing in acute coronary syndrome patients.
    Straub N; Beivers A; Lenk E; Aradi D; Sibbing D
    Thromb Haemost; 2014 Feb; 111(2):290-9. PubMed ID: 24154566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preoperative Ticagrelor administration leads to a higher risk of bleeding during and after coronary bypass surgery in a case-matched analysis.
    Schaefer A; Sill B; Schoenebeck J; Schneeberger Y; Kubik M; Reichenspurner H; Gulbins H
    Interact Cardiovasc Thorac Surg; 2016 Feb; 22(2):136-40. PubMed ID: 26519259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimal timing of clopidogrel discontinuation in Japanese patients: platelet aggregation test using the VerifyNow® system.
    Takiuchi H; Tanemoto K
    Gen Thorac Cardiovasc Surg; 2015 Nov; 63(11):601-6. PubMed ID: 26298730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative Efficacy and Safety of Prasugrel, Ticagrelor, and Standard-Dose and High-Dose Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention: A Network Meta-analysis.
    Singh S; Singh M; Grewal N; Khosla S
    Am J Ther; 2016; 23(1):e52-62. PubMed ID: 26448337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discharge aspirin dose and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel: an analysis from the TRITON-TIMI 38 study (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38).
    Kohli P; Udell JA; Murphy SA; Cannon CP; Antman EM; Braunwald E; Wiviott SD
    J Am Coll Cardiol; 2014 Jan; 63(3):225-32. PubMed ID: 24140678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potent P2Y
    Lau ES; Braunwald E; Murphy SA; Wiviott SD; Bonaca MP; Husted S; James SK; Wallentin L; Clemmensen P; Roe MT; Ohman EM; Harrington RA; Mega JL; Bhatt DL; Sabatine MS; O'Donoghue ML
    J Am Coll Cardiol; 2017 Mar; 69(12):1549-1559. PubMed ID: 28335837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Third generation P2Y12 antagonists inhibit platelet aggregation more effectively than clopidogrel in a myocardial infarction registry.
    Olivier CB; Diehl P; Schnabel K; Weik P; Zhou Q; Bode C; Moser M
    Thromb Haemost; 2014 Feb; 111(2):266-72. PubMed ID: 24172891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Recent advances on the studies of the platelet's inhibition and aggregation. State of the art of new P2Y12 antagonists].
    Cattaneo GJ; Podda GM; Cattaneo M
    Recenti Prog Med; 2011 Apr; 102(4):150-5. PubMed ID: 21572491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual antiplatelet therapy with prasugrel or ticagrelor versus clopidogrel in interventional cardiology.
    Clemmensen P; Dridi NP; Holmvang L
    Cardiovasc Drugs Ther; 2013 Jun; 27(3):239-45. PubMed ID: 23380983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Meta-analysis of Comparison of the Newer P2Y12 Inhibitors (Oral Preparation or Intravenous) to Clopidogrel in Patients With Acute Coronary Syndrome.
    Zhang L; Lu J; Dong W; Tian H; Feng W; You H; He H; Ma J; Dong Y
    J Cardiovasc Pharmacol; 2017 Mar; 69(3):147-155. PubMed ID: 27922911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of clopidogrel loading dose on clinical outcome in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis.
    Siller-Matula JM; Huber K; Christ G; Schrör K; Kubica J; Herkner H; Jilma B
    Heart; 2011 Jan; 97(2):98-105. PubMed ID: 20736210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of preoperative angiotensin-converting enzyme inhibitor on the outcome of coronary artery bypass graft surgery.
    Zhang Y; Ma L
    Eur J Cardiothorac Surg; 2015 May; 47(5):788-95. PubMed ID: 25079771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of new adenosine diphosphate receptor antagonists with clopidogrel in patients with coronary artery disease: a meta-analysis.
    Bae JS; Jang JS
    Heart Vessels; 2016 Mar; 31(3):275-87. PubMed ID: 25374111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.